Intrauterine adhesion after missed miscarriage evacuation: efficacy of different estrogen doses on incidence and risk factors.
Аннотация
OBJECTIVE
To compare the efficacy of different doses of estradiol valerate in preventing intrauterine adhesion (IUA) incidence and promoting endometrial recovery after curettage for retained abortion.
METHODS
A total of 188 patients who underwent Missed Miscarriage (MM) by curettage were retrospectively assigned to three groups based on the preoperative estradiol valerate dosage: Group A (3 mg/day), Group B (5 mg/day), and Group C (no estrogen). Postoperative outcomes, including IUA incidence (assessed by hysteroscopy), endometrial thickness (transvaginal ultrasound), menstrual recovery, and adverse reactions, were compared among groups. Logistic regression and ROC curve analysis were used to identify independent risk factors for IUA.
RESULTS
Group B showed the lowest IUA incidence (4.84% vs. 7.14% in Group A and 21.43% in Group C, P < 0.001), greater endometrium thickness at 14 days postoperatively, and shorter menstrual recovery time (P < 0.001). Preoperative endometrial thickness < 4 mm and a history of IUA were identified as independent risk factors (AUC = 0.760). The incidence of adverse reactions did not differ significantly among the groups (P > 0.05).
CONCLUSION
Preoperative administration of 5 mg/day estradiol valerate significantly reduces IUA incidence and enhances endometrial recovery after curettage. A thin endometrium and prior IUA history are key risk factors for postoperative adhesion formation.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.